Disease | colorectal cancer |
Symptom | C0021079|immune suppression |
Sentences | 1 |
PubMedID- 22270330 | These finding suggest that gm-csf can abrogate important aspects of the immune suppression seen in patients with advanced colorectal cancer and may provide a non-toxic intervention to augment anti-tumor immunity for cancer patients receiving cytotoxic chemotherapy. |
Page: 1